✦ LIBER ✦

A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer

✍ Scribed by Modi, Shanu; Saura, Cristina; Henderson, Charles; Lin, Nancy U.; Mahtani, Reshma; Goddard, Jill; Rodenas, Eduardo; Hudis, Clifford; O’Shaughnessy, Joyce; Baselga, Jose

Book ID: 121637763
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 287 KB
Volume: 139
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-013-2510-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Gemcitabine/Carboplati

Phase II Trial of Gemcitabine/Carboplatin (plus Trastuzumab in HER2-Positive Disease) in Patients with Metastatic Breast Cancer

✍ David Loesch; Lina Asmar; Kristi McIntyre; Lisa Doane; Michael Monticelli; Devch 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 132 KB

Phase Ib Study of Buparlisib plus Trastu

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

✍ Saura, C.; Bendell, J.; Jerusalem, G.; Su, S.; Ru, Q.; De Buck, S.; Mills, D.; R 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 898 KB

A phase II trial of trastuzumab plus wee

A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial

✍ Stacy Moulder; Hailun Li; Molin Wang; William J. Gradishar; Edith A. Perez; Jose 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 250 KB

Randomized phase III trial of trastuzuma

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group

✍ Kenichi Inoue; Kazuhiko Nakagami; Mitsuhiro Mizutani; Yasuo Hozumi; Yasuhiro Fuj 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 368 KB

A Meta-Analysis of Randomized Controlled

A Meta-Analysis of Randomized Controlled Trials Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Alone in HER-2-Positive Advanced Breast Cancer

✍ Cun Liao; Fang Yin; Ping Huang; Yunfei Cao; Feng Gao 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB

Trastuzumab plus docetaxel with or witho

Trastuzumab plus docetaxel with or without capecitabine as first-line therapy for HER2-positive locally advanced or metastatic breast cancer: a randomised Phase II study

✍ A. Wardlev; A. Anton-Torres; X. Pivot; F. Morales-Vasquez; L. Zetina; M. de Fati 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB